Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy
暂无分享，去创建一个
R. Naumann | M. von Bergwelt-Baildon | C. Trenker | M. Subklewe | E. Bachy | C. Schmidt | P. Sesques | A. Burchert | J. Schäfer | G. Iacoboni | L. Fransecky | V. Buecklein | K. Rejeski | V. Blumenberg | P. Barba | K. Sohlbach | R. Hernani